News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Conference News ESC 2021 IAMI: Influenza Vaccine Beneficial for Post-MI Patients Michael O'Riordan August 30, 2021
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News ESC 2021 Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’ L.A. McKeown August 28, 2021
News Daily News Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2 Michael O'Riordan August 26, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Conference News SCCT 2021 COVID-19’s Effects on Cardiac Imaging Protocols, Perspectives Still Unfolding Yael L. Maxwell July 23, 2021
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Daily News Big Downturn in CVD Procedures Seen During COVID-19’s First Wave Michael O'Riordan July 01, 2021
News Daily News Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA L.A. McKeown June 23, 2021
News Daily News LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD Michael O'Riordan June 18, 2021
News Daily News Stark Drop in CV Imaging in Early COVID-19 Offers Food for Thought Shelley Wood June 17, 2021
News Daily News Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors Michael O'Riordan June 16, 2021